首页> 外国专利> Illness period classification of prostate cancer/gun

Illness period classification of prostate cancer/gun

机译:前列腺癌/枪支的疾病时期分类

摘要

(57) Abstract This invention in order illness period to classify the prostate cancer/gun, namely the organ limit bureau characteristic prostate cancer/gun of the patient (PCa) here, human gland characteristic kalium credit in of the body fluids of the patient 2 (hK2) and the prostate unique antigen (PSA) is decided optionally in regard to the method of discriminating organ non limit bureau characteristic PCa. In this method, hK2 is used the patient who possesses organ limit bureau characteristic PCa, as the marker which is classified from the patient who possesses organ non limit bureau characteristic PCa. Furthermore, as for this invention here, human gland characteristic kalium credit in of the body fluids of the patient 2 (hK2) is decided in order degree of malignancy to classify the prostate cancer/gun, namely the prostate cancer/gun which is being advanced attack (PCa) in regard to the method in order to discriminate from the patient who possesses PCa which excessively attack is not advancing the patient whom it possesses. In this method, hK2 it is used independently as the aforementioned marker.
机译:(57)<摘要>本发明为了将疾病时期分类为前列腺癌/枪支,即这里的患者的器官极限局特征性前列腺癌/枪支,人腺体特征性钾的摄入量对于患者2(hK2)和前列腺独特抗原(PSA)的选择,要根据区分器官非极限局特征PCa的方法来决定。在该方法中,将hK2用作具有​​器官极限局特性PCa的患者,作为从具有器官非极限局特性PCa的患者进行分类的标记。此外,在此的本发明中,为了对前列腺癌/枪,即正在发展的前列腺癌/枪进行分类的恶性程度,决定患者2的体液中的人腺特征性钾的摄取量(hK2)。为了区别于拥有PCa的患者的方法(PCa),过度攻击不会使拥有其的患者前进。在该方法中,hK2单独用作上述标记。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号